Variant report

Variant	nsv883359
Chromosome Location	chr6:394293-516350
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:0)
CpG islands
(count:0)
Chromatin interactive
region (count:73)
LncRNA
region (count:3)
Mature miRNA
region (count: 0)
miRNA target
sites (count:3)

No data

(count:73 , 50 per page) page: 1 2

No.	Distal block	Cell Line	Cell type
1	chr6:467084..468601-chr6:470547..472837,2	MCF-7	breast:
2	chr6:351167..352344-chr6:408672..409414,4	MCF-7	breast:
3	chr6:466967..469426-chr6:471037..473019,2	K562	blood:
4	chr6:412558..415332-chr6:420167..422817,2	K562	blood:
5	chr6:454198..456749-chr6:458940..460781,2	K562	blood:
6	chr6:394972..397659-chr6:402039..404280,2	MCF-7	breast:
7	chr6:423651..426964-chr6:426983..431390,3	K562	blood:
8	chr6:188512..189290-chr6:408309..409342,5	K562	blood:
9	chr6:291167..293410-chr6:407998..409657,2	MCF-7	breast:
10	chr6:502434..504498-chr6:504512..507220,2	MCF-7	breast:
11	chr6:452619..455304-chr6:464046..466915,2	K562	blood:
12	chr6:452619..455304-chr6:464046..466915,2	K562	blood:
13	chr6:499255..501775-chr6:512094..513788,2	K562	blood:
14	chr6:453677..456458-chr6:461551..464180,2	K562	blood:
15	chr6:414625..416916-chr6:423887..426653,2	K562	blood:
16	chr6:423338..426540-chr6:426983..429484,4	K562	blood:
17	chr6:226916..227829-chr6:408545..409059,2	K562	blood:
18	chr6:495786..498044-chr6:509151..511366,2	K562	blood:
19	chr15:78934757..78935629-chr6:491957..492824,2	MCF-7	breast:
20	chr6:465774..468570-chr6:469900..472566,3	K562	blood:
21	chr6:465774..468570-chr6:469900..472566,3	K562	blood:
22	chr6:188538..189926-chr6:408487..409481,6	MCF-7	breast:
23	chr6:474698..477221-chr6:477805..479723,2	K562	blood:
24	chr6:408762..409286-chr6:489445..489959,2	MCF-7	breast:
25	chr6:495786..498044-chr6:509151..511366,2	K562	blood:
26	chr6:516023..518529-chr6:547160..548898,2	K562	blood:
27	chr6:439906..443284-chr6:445258..447366,3	K562	blood:
28	chr6:437166..439679-chr6:441319..444168,2	MCF-7	breast:
29	chr6:414625..416916-chr6:423887..426653,2	K562	blood:
30	chr6:328240..330031-chr6:473438..476214,2	MCF-7	breast:
31	chr6:188540..189516-chr6:407870..409552,18	MCF-7	breast:
32	chr6:461019..462992-chr6:464087..466836,2	K562	blood:
33	chr6:402138..404117-chr6:404405..405938,2	K562	blood:
34	chr6:479740..482609-chr6:484854..487797,2	K562	blood:
35	chr6:439020..441406-chr6:445866..448274,2	K562	blood:
36	chr6:466967..469426-chr6:471037..473019,2	K562	blood:
37	chr6:446435..449221-chr6:451898..454724,3	K562	blood:
38	chr6:402926..405329-chr6:407204..410322,3	K562	blood:
39	chr6:394972..397659-chr6:402039..404280,2	MCF-7	breast:
40	chr6:479740..482609-chr6:484854..487797,2	K562	blood:
41	chr6:408762..409286-chr6:489445..489959,2	MCF-7	breast:
42	chr6:467084..468601-chr6:470547..472837,2	MCF-7	breast:
43	chr6:423338..426540-chr6:426983..429484,4	K562	blood:
44	chr6:482791..485178-chr6:487911..490396,2	K562	blood:
45	chr6:290942..293204-chr6:406060..408033,2	MCF-7	breast:
46	chr6:328412..329240-chr6:408584..409212,2	MCF-7	breast:
47	chr6:355994..357580-chr6:409667..411227,2	K562	blood:
48	chr6:453677..456458-chr6:461551..464180,2	K562	blood:
49	chr6:402926..405329-chr6:407204..410322,3	K562	blood:
50	chr6:437166..439679-chr6:441319..444168,2	MCF-7	breast:

(count:3 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-IRF4-4	chr6:444524-444855	NONHSAT106052
2	lnc-IRF4-5	chr6:481970-482301	NONHSAT106056
3	lnc-IRF4-4	chr6:444487-444818	NONHSAT106051

No data

(count:3 , 50 per page) page: 1

No.	miRNA target gene	miRNA name	Chromosome Location
1	IRF4	hsa-miR-125b-5p	chr6:410038-410062
2	IRF4	hsa-miR-125b-5p	chr6:408190-408197
3	IRF4	hsa-miR-125b-5p	chr6:408176-408197

Variant related genes	Relation type
ENSG00000137265	chromatin interactions
ENSG00000112679	chromatin interactions
ENSG00000230433	chromatin interactions

Extended variants
information (count: 6550 )
Associated
traits (count: 71 )

Variant overlapped rSNPs/rCNVs (count:6550 , 50 per page) page: 1 2 3 4 5 6 7 ... 131

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs2797307	chr6:394293-394294	Bivalent Enhancer Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Weak transcription Bivalent/Poised TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
2	rs534034778	chr6:394302-394303	Bivalent Enhancer Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Weak transcription Bivalent/Poised TSS	n/a	n/a	Overlapped CNVs	n/a
3	rs57300680	chr6:394329-394330	Bivalent Enhancer Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Weak transcription Bivalent/Poised TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
4	rs570555714	chr6:394399-394400	Bivalent Enhancer Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Weak transcription Bivalent/Poised TSS	n/a	n/a	Overlapped CNVs	n/a
5	rs539810964	chr6:394403-394404	Bivalent Enhancer Transcr. at gene 5' and 3' Genic enhancers Enhancers Weak transcription Flanking Active TSS Bivalent/Poised TSS	n/a	n/a	Overlapped CNVs	n/a
6	rs556612603	chr6:394404-394405	Bivalent Enhancer Transcr. at gene 5' and 3' Genic enhancers Enhancers Weak transcription Flanking Active TSS Bivalent/Poised TSS	n/a	n/a	Overlapped CNVs	n/a
7	rs377399870	chr6:394443-394444	Bivalent Enhancer Transcr. at gene 5' and 3' Genic enhancers Enhancers Weak transcription Flanking Active TSS Bivalent/Poised TSS	n/a	n/a	Overlapped CNVs	n/a
8	rs535745683	chr6:394476-394477	Bivalent Enhancer Transcr. at gene 5' and 3' Genic enhancers Enhancers Weak transcription Flanking Active TSS Bivalent/Poised TSS	n/a	n/a	Overlapped CNVs	n/a
9	rs556006415	chr6:394488-394489	Bivalent Enhancer Transcr. at gene 5' and 3' Genic enhancers Enhancers Weak transcription Flanking Active TSS Bivalent/Poised TSS	n/a	n/a	Overlapped CNVs	n/a
10	rs570153443	chr6:394528-394529	Bivalent Enhancer Transcr. at gene 5' and 3' Genic enhancers Enhancers Weak transcription Flanking Active TSS Bivalent/Poised TSS	n/a	n/a	Overlapped CNVs	n/a
11	rs540377898	chr6:394536-394537	Bivalent Enhancer Transcr. at gene 5' and 3' Genic enhancers Enhancers Weak transcription Flanking Active TSS Bivalent/Poised TSS	n/a	n/a	Overlapped CNVs	n/a
12	rs374779996	chr6:394593-394594	Bivalent Enhancer Transcr. at gene 5' and 3' Genic enhancers Enhancers Weak transcription Flanking Active TSS Bivalent/Poised TSS	n/a	n/a	Overlapped CNVs	n/a
13	rs560282242	chr6:394603-394604	Bivalent Enhancer Genic enhancers Enhancers Weak transcription Transcr. at gene 5' and 3' Strong transcription Bivalent/Poised TSS	n/a	n/a	Overlapped CNVs	n/a
14	rs200743910	chr6:394632-394633	Bivalent Enhancer Genic enhancers Enhancers Weak transcription Transcr. at gene 5' and 3' Strong transcription Bivalent/Poised TSS	n/a	n/a	Overlapped CNVs	n/a
15	rs2671428	chr6:394643-394644	Bivalent Enhancer Genic enhancers Enhancers Weak transcription Transcr. at gene 5' and 3' Strong transcription Bivalent/Poised TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
16	rs148625904	chr6:394648-394649	Bivalent Enhancer Genic enhancers Enhancers Weak transcription Transcr. at gene 5' and 3' Strong transcription Bivalent/Poised TSS	n/a	n/a	Overlapped CNVs	n/a
17	rs2797308	chr6:394711-394712	Bivalent Enhancer Genic enhancers Enhancers Weak transcription Transcr. at gene 5' and 3' Strong transcription Bivalent/Poised TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
18	rs548038312	chr6:394757-394758	Bivalent Enhancer Genic enhancers Enhancers Weak transcription Transcr. at gene 5' and 3' Strong transcription Bivalent/Poised TSS	n/a	n/a	Overlapped CNVs	n/a
19	rs561546511	chr6:394768-394769	Bivalent Enhancer Genic enhancers Enhancers Weak transcription Transcr. at gene 5' and 3' Strong transcription Bivalent/Poised TSS	n/a	n/a	Overlapped CNVs	n/a
20	rs367593784	chr6:394784-394785	Bivalent Enhancer Genic enhancers Enhancers Weak transcription Transcr. at gene 5' and 3' Strong transcription Bivalent/Poised TSS	n/a	n/a	Overlapped CNVs	n/a
21	rs371768937	chr6:394796-394797	Bivalent Enhancer Genic enhancers Enhancers Weak transcription Transcr. at gene 5' and 3' Strong transcription Bivalent/Poised TSS	n/a	n/a	Overlapped CNVs	n/a
22	rs144593192	chr6:394866-394867	Bivalent Enhancer Genic enhancers Enhancers Weak transcription Transcr. at gene 5' and 3' Strong transcription	n/a	n/a	Overlapped CNVs	n/a
23	rs202124383	chr6:394867-394868	Bivalent Enhancer Genic enhancers Enhancers Weak transcription Transcr. at gene 5' and 3' Strong transcription	n/a	n/a	Overlapped CNVs	n/a
24	rs116609963	chr6:394880-394881	Bivalent Enhancer Genic enhancers Enhancers Weak transcription Transcr. at gene 5' and 3' Strong transcription	n/a	n/a	Overlapped CNVs	n/a
25	rs145478558	chr6:394889-394890	Bivalent Enhancer Genic enhancers Enhancers Weak transcription Transcr. at gene 5' and 3' Strong transcription	n/a	n/a	Overlapped CNVs	n/a
26	rs200303421	chr6:394918-394919	Bivalent Enhancer Genic enhancers Enhancers Weak transcription Transcr. at gene 5' and 3' Strong transcription	n/a	n/a	Overlapped CNVs	n/a
27	rs374588785	chr6:394932-394933	Bivalent Enhancer Genic enhancers Enhancers Weak transcription Transcr. at gene 5' and 3' Strong transcription	n/a	n/a	Overlapped CNVs	n/a
28	rs112896428	chr6:394958-394959	Bivalent Enhancer Genic enhancers Enhancers Weak transcription Transcr. at gene 5' and 3' Strong transcription	n/a	n/a	Overlapped CNVs	n/a
29	rs200504236	chr6:395009-395010	Bivalent Enhancer Genic enhancers Enhancers Weak transcription Transcr. at gene 5' and 3' Strong transcription	n/a	n/a	Overlapped CNVs	n/a
30	rs62389393	chr6:395013-395014	Bivalent Enhancer Genic enhancers Enhancers Weak transcription Transcr. at gene 5' and 3' Strong transcription	n/a	n/a	Overlapped CNVs	n/a
31	rs369623460	chr6:395016-395017	Bivalent Enhancer Genic enhancers Enhancers Weak transcription Transcr. at gene 5' and 3' Strong transcription	n/a	n/a	Overlapped CNVs	n/a
32	rs569910593	chr6:395087-395088	Bivalent Enhancer Genic enhancers Enhancers Weak transcription Transcr. at gene 5' and 3' Strong transcription	n/a	n/a	Overlapped CNVs	n/a
33	rs147511488	chr6:395108-395109	Bivalent Enhancer Genic enhancers Enhancers Weak transcription Transcr. at gene 5' and 3' Strong transcription	n/a	n/a	Overlapped CNVs	n/a
34	rs374767513	chr6:395109-395110	Bivalent Enhancer Genic enhancers Enhancers Weak transcription Transcr. at gene 5' and 3' Strong transcription	n/a	n/a	Overlapped CNVs	n/a
35	rs550905460	chr6:395112-395113	Bivalent Enhancer Genic enhancers Enhancers Weak transcription Transcr. at gene 5' and 3' Strong transcription	n/a	n/a	Overlapped CNVs	n/a
36	rs536150712	chr6:395181-395182	Bivalent Enhancer Genic enhancers Enhancers Weak transcription Transcr. at gene 5' and 3' Strong transcription	n/a	n/a	Overlapped CNVs	n/a
37	rs556093990	chr6:395186-395187	Bivalent Enhancer Genic enhancers Enhancers Weak transcription Transcr. at gene 5' and 3' Strong transcription	n/a	n/a	Overlapped CNVs	n/a
38	rs181192513	chr6:395231-395232	Bivalent Enhancer Genic enhancers Strong transcription Enhancers Weak transcription Transcr. at gene 5' and 3'	n/a	n/a	Overlapped CNVs	n/a
39	rs567666072	chr6:395238-395239	Bivalent Enhancer Genic enhancers Strong transcription Enhancers Weak transcription Transcr. at gene 5' and 3'	n/a	n/a	Overlapped CNVs	n/a
40	rs11369013	chr6:395239-395240	Bivalent Enhancer Genic enhancers Strong transcription Enhancers Weak transcription Transcr. at gene 5' and 3'	n/a	n/a	Overlapped CNVs	n/a
41	rs532831581	chr6:395243-395244	Bivalent Enhancer Genic enhancers Strong transcription Enhancers Weak transcription Transcr. at gene 5' and 3'	n/a	n/a	Overlapped CNVs	n/a
42	rs374628027	chr6:395247-395248	Bivalent Enhancer Genic enhancers Strong transcription Enhancers Weak transcription Transcr. at gene 5' and 3'	n/a	n/a	Overlapped CNVs	n/a
43	rs535217176	chr6:395252-395253	Bivalent Enhancer Genic enhancers Strong transcription Enhancers Weak transcription Transcr. at gene 5' and 3'	n/a	n/a	Overlapped CNVs	n/a
44	rs369029146	chr6:395291-395292	Bivalent Enhancer Genic enhancers Strong transcription Enhancers Weak transcription Transcr. at gene 5' and 3'	n/a	n/a	Overlapped CNVs	n/a
45	rs553940070	chr6:395297-395298	Bivalent Enhancer Genic enhancers Strong transcription Enhancers Weak transcription Transcr. at gene 5' and 3'	n/a	n/a	Overlapped CNVs	n/a
46	rs536537776	chr6:395337-395338	Bivalent Enhancer Genic enhancers Strong transcription Enhancers Weak transcription Transcr. at gene 5' and 3'	n/a	n/a	Overlapped CNVs	n/a
47	rs6930092	chr6:395349-395350	Bivalent Enhancer Genic enhancers Strong transcription Enhancers Weak transcription Transcr. at gene 5' and 3'	n/a	n/a	Overlapped CNVs	n/a
48	rs113413101	chr6:395351-395352	Bivalent Enhancer Genic enhancers Strong transcription Enhancers Weak transcription Transcr. at gene 5' and 3'	n/a	n/a	Overlapped CNVs	n/a
49	rs79651559	chr6:395359-395360	Bivalent Enhancer Genic enhancers Strong transcription Enhancers Weak transcription Transcr. at gene 5' and 3'	n/a	n/a	Overlapped CNVs	n/a
50	rs116544972	chr6:395362-395363	Bivalent Enhancer Genic enhancers Strong transcription Enhancers Weak transcription Transcr. at gene 5' and 3'	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:71)

Disease	PMID	Source
Chronic lymphocytic leukemia	21546498	CNVD
Myelofibrosis	22110671	CNVD
Barrett''s adenocarcinoma	18663352	CNVD
Prader-willi syndrome	20588305	CNVD
Multiple myeloma	16616336	CNVD
Acute lymphoblastic leukemia	21098271	CNVD
Developmental delay	19490664	CNVD
Cancer	21183584	CNVD
Multiple Epiphyseal Dysplasia	20877625	CNVD
Congenital diaphragmatic hernia	21085971	CNVD
Glaucoma	18694899	CNVD
High-grade prostatic intraepithelial neoplasia	16573809	CNVD
Prostate cancer	16573809	CNVD
Acute lymphoblastic leukemia	21980252	CNVD
Breast cancer	17603634	CNVD
Cancer	20164920	CNVD
Colorectal cancer	21297112	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Follicular lymphoma	20505157	CNVD
Glioblastoma multiforme	21080181	CNVD
Ewing''s sarcoma	21437220	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Leukemia	21518781	CNVD
Cancer	21637783	CNVD
Facial dysmorphism	22105932	CNVD
Medulloblastoma	21979893	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Diffuse large b-cell lymphoma	18287131	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	19960244	CNVD
Hepatocellular carcinoma	22174799	CNVD
Endometrial cancer	22040021	CNVD
Acute myeloid leukemia	16864856	CNVD
Breast cancer	21264507	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Cancer	16751803	CNVD
Bladder cancer	19088036	CNVD
Wilms tumour	21544195	CNVD
Uveal melanoma	21693616	CNVD
Biliary cancer	19435499	CNVD
Malaria	21533027	CNVD
Non-syndromic sensorineural hearing loss	17122850	CNVD
small cell lung cancer	20016488	CNVD
Retinoblastoma	19183342	CNVD
Acute myeloid leukemia	20729466	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Lung cancer	18438408	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Lung cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Non-syndromic sensorineural hearing loss	15273396	CNVD
Prostate cancer	18632612	CNVD
Myelodysplastic syndrome	21251322	CNVD
low-grade B-cell lymphoma tumor	18367492	CNVD
Breast cancer	21858162	CNVD
Breast cancer	21364760	CNVD
Bladder cancer	21909424	CNVD
Multiple myeloma	17550852	CNVD
Ewing''s sarcoma	17952124	CNVD
Non-syndromic sensorineural hearing loss	18451855	CNVD
Cancer	20164919	CNVD
Pancreatic cancer	17952125	CNVD
Breast cancer	22522925	CNVD
Schizophrenia	23813976	CNVD
Non-syndromic sensorineural hearing loss	19587683	CNVD

Chromatin state (count:2290 , 50 per page) page: 1 2 3 4 5 6 7 ... 46

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr6:390000-394800	Bivalent/Poised TSS	Rectal Mucosa Donor 29	rectum
2	chr6:391000-394400	Bivalent Enhancer	Cortex derived primary cultured neurospheres	brain
3	chr6:391200-400600	Transcr. at gene 5' and 3'	Primary T helper 17 cells PMA-I stimulated	--
4	chr6:392000-406400	Transcr. at gene 5' and 3'	Primary T helper cells PMA-I stimulated	--
5	chr6:392200-394400	Flanking Bivalent TSS/Enh	Monocytes-CD14+_RO01746	blood
6	chr6:392800-396000	Transcr. at gene 5' and 3'	Foreskin Melanocyte Primary Cells skin03	Skin
7	chr6:393200-394400	Bivalent/Poised TSS	Colonic Mucosa	Colon
8	chr6:393400-396600	Transcr. at gene 5' and 3'	Foreskin Melanocyte Primary Cells skin01	Skin
9	chr6:393600-394400	Flanking Bivalent TSS/Enh	Primary T cells fromperipheralblood	blood
10	chr6:393600-394400	Flanking Active TSS	Primary T helper cells fromperipheralblood	blood
11	chr6:393800-394400	Transcr. at gene 5' and 3'	Primary B cells from peripheral blood	blood
12	chr6:393800-394400	Flanking Active TSS	Primary T helper naive cells from peripheral blood	blood
13	chr6:393800-394400	Flanking Active TSS	Primary T helper naive cells fromperipheralblood	blood
14	chr6:393800-394400	Bivalent Enhancer	Skeletal Muscle Female	skeletal muscle
15	chr6:393800-396600	Transcr. at gene 5' and 3'	GM12878-XiMat	blood
16	chr6:393800-397600	Weak transcription	Esophagus	oesophagus
17	chr6:394000-394400	Flanking Bivalent TSS/Enh	Primary T cells from cord blood	blood
18	chr6:394000-394400	Flanking Active TSS	Primary T helper memory cells from peripheral blood 2	blood
19	chr6:394000-394400	Flanking Active TSS	Primary T killer memory cells from peripheral blood	blood
20	chr6:394000-394400	Bivalent Enhancer	Primary hematopoietic stem cells G-CSF-mobilized Female	--
21	chr6:394000-394600	Bivalent Enhancer	Primary monocytes fromperipheralblood	blood
22	chr6:394000-394600	Transcr. at gene 5' and 3'	Primary B cells from cord blood	blood
23	chr6:394000-394600	Flanking Active TSS	Primary T regulatory cells fromperipheralblood	blood
24	chr6:394000-396400	Enhancers	Placenta Amnion	Placenta Amnion
25	chr6:394200-394400	Bivalent Enhancer	H1 Cell Line	embryonic stem cell
26	chr6:394200-394400	Bivalent Enhancer	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
27	chr6:394200-394400	Bivalent Enhancer	HUES48 Cell Line	embryonic stem cell
28	chr6:394200-394400	Bivalent Enhancer	HUES6 Cell Line	embryonic stem cell
29	chr6:394200-394400	Bivalent Enhancer	iPS-15b Cell Line	embryonic stem cell
30	chr6:394200-394400	Bivalent Enhancer	iPS-18 Cell Line	embryonic stem cell
31	chr6:394200-394400	Bivalent Enhancer	Primary hematopoietic stem cells	blood
32	chr6:394200-394400	Enhancers	Primary T helper memory cells from peripheral blood 1	blood
33	chr6:394200-394400	Bivalent Enhancer	Primary Natural Killer cells fromperipheralblood	blood
34	chr6:394200-394400	Bivalent Enhancer	Primary hematopoietic stem cells G-CSF-mobilized Male	--
35	chr6:394200-394400	Bivalent Enhancer	Primary mononuclear cells fromperipheralblood	Blood
36	chr6:394200-394400	Bivalent Enhancer	Brain Hippocampus Middle	brain
37	chr6:394200-394400	Bivalent Enhancer	Fetal Thymus	thymus
38	chr6:394200-395000	Enhancers	Primary T killer naive cells fromperipheralblood	blood
39	chr6:394200-401400	Weak transcription	Spleen	Spleen
40	chr6:394200-403400	Weak transcription	Primary T cells effector/memory enriched fromperipheralblood	blood
41	chr6:394400-394600	Enhancers	Primary T helper cells fromperipheralblood	blood
42	chr6:394400-394600	Weak transcription	Primary mononuclear cells fromperipheralblood	Blood
43	chr6:394400-394800	Bivalent Enhancer	Primary T cells fromperipheralblood	blood
44	chr6:394400-395000	Bivalent Enhancer	Primary T cells from cord blood	blood
45	chr6:394400-395000	Enhancers	Primary T helper naive cells fromperipheralblood	blood
46	chr6:394400-395000	Enhancers	Primary T killer memory cells from peripheral blood	blood
47	chr6:394400-395400	Enhancers	Primary T helper memory cells from peripheral blood 2	blood
48	chr6:394400-399000	Weak transcription	Primary T helper naive cells from peripheral blood	blood
49	chr6:394400-405800	Genic enhancers	Primary B cells from peripheral blood	blood
50	chr6:394600-395200	Bivalent Enhancer	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links